Oral Lichenoid Reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings

Ítems similars

• Characterization and management of dermatologic adverse events to agents targeting the PD-1 receptor
  per: Belum, V.R., et al.
  Publicat: (2016)
• Non-infectious granulomatous disorders of the upper lip: clinicopathological analysis of 11 patients
  per: Irene Lafuente-Ibáñez de Mendoza, et al.
  Publicat: (2022-05-01)
• Immune-related alopecia (areata and universalis-type) in cancer patients receiving immune checkpoint inhibitors
  per: Zarbo, A., et al.
  Publicat: (2017)
• Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
  per: Naidoo, J., et al.
  Publicat: (2016)
• Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
  per: Naidoo, J., et al.
  Publicat: (2015)